Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0964020120120010051
Journal of the Korean Liver Cancer Study Group
2012 Volume.12 No. 1 p.51 ~ p.57
A Case of Advanced Hepatocellular Carcinoma which was Supervening with Renal Cell Cancer Cured by Repeated Transarterial Chemoembolization and Sorafenib after Resection
Kim Bun

Min Jae-Hoon
Kim Seung-Up
Park Jun-Yong
Lee Kwang-Hoon
Lee Do-Youn
Choi Jin-Sub
Choi Young-Deuk
Cho Nam-Hoon
Park Young-Nyun
Ahn Sang-Hoon
Han Kwang-Hyub
Chon Chae-Yoon
Kim Do-Young
Abstract
Advanced hepatocellular carcinoma (HCC) is difficult to treat and the survival is poor. Here, we present a patient diagnosed as advanced HCC (stage IIIa) which was supervening with early renal cell cancer (stage I). The patient was treated with pre-operational transarterial chemoembolization (TACE) and surgical resection (right hepatectomy, right nephrectomy, and cholecystectomy). Sorafenib were taken continually after surgery. Multiple recurred HCC nodules in remnant liver were detected 2 months later after surgery. Combined treatment modalities including 4 sessions of TACE, and 12 cycles of 5-flurouracil (FU)/carboplatin based hepatic arterial infusional chemotherapy (HAIC) induced complete response. After the diagnosis of advanced HCC, the patient survived 36 months and experienced disease-free status for 19 months.
KEYWORD
Hepatocellular carcinoma, Renal cell carcinoma, Sorafenib, Transarterial chemoembolization, Hepatic artery infusional chemotherapy, Resection
FullTexts / Linksout information
Listed journal information